Baker Bros. Advisors Lp
Affiliations
- Large Shareholder, Director at Kodiak Sciences Inc. (KOD), 2022-07-05
- Large Shareholder, Director at Incyte Corp (INCY), 2022-07-01
- Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2022-06-30
- Large Shareholder, Director at Beigene Ltd. (BGNE), 2022-06-24
- Large Shareholder, Director at Prelude Therapeutics Inc (PRLD), 2022-06-22
- Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2022-06-13
- Large Shareholder, Director at Dbv Technologies S.a. (DBVT), 2022-06-13
- Large Shareholder, Director at Acadia Pharmaceuticals Inc (ACAD), 2022-06-09
- Large Shareholder at Entrada Therapeutics Inc. (TRDA), 2022-06-06
- Large Shareholder, Director at Tscan Therapeutics Inc. (TCRX), 2022-06-03
- Large Shareholder, Director at Seagen Inc. (SGEN), 2022-05-17
- Director at Neoleukin Therapeutics Inc. (NLTX), 2022-05-16
- Large Shareholder, Director at Igm Biosciences Inc. (IGMS), 2022-04-05
- Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
- Large Shareholder at Atreca Inc. (BCEL), 2020-07-20
- Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
- Director at Zymeworks Inc. (ZYME), 2020-05-12
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
- Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
- Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
- Large Shareholder at Invitae Corp (NVTA), 2018-03-29
- Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2018-01-19
- Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
- Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
- Other at Xoma Corp (XOMA), 2015-07-23
- Other at Synageva Biopharma Corp (GEVA), 2015-06-23
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| KOD | $7.78 | 170,549 | Large Shareholder, Director | 15,967,504 | 2022-06-06 | Filing | |
| KOD | $7.78 | 20,108 | Large Shareholder, Director | 1,342,986 | 2022-06-06 | Filing | |
| KOD | $7.75 | 101,315 | Large Shareholder, Director | 15,796,955 | 2022-06-06 | Filing | |
| KOD | $7.75 | 11,945 | Large Shareholder, Director | 1,322,878 | 2022-06-06 | Filing | |
| KOD | $7.95 | 78,271 | Large Shareholder, Director | 15,695,640 | 2022-06-03 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| SGEN | $161.39 | 51,399 | 42,947,504 | 2021-12-01 | Filing | ||
| SGEN | $161.39 | 4,738 | 4,069,762 | 2021-12-01 | Filing | ||
| SGEN | $161.35 | 8,332 | 42,998,903 | 2021-12-01 | Filing | ||
| SGEN | $161.35 | 768 | 4,074,500 | 2021-12-01 | Filing | ||
| SGEN | $160.80 | 25,833 | 43,007,235 | 2021-12-01 | Filing |